Your Messages Inbox
Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Takeda, Amgen to suspend trials of cancer drug
Corporate News Releases - The Healthcare Sales & Marketing Network, 11/20/08
Japan's Takeda Pharmaceutical Co and U.S. biotech firm Amgen Inc said they would suspend enrolment in the last-stage trials of a key cancer drug candidate following negative study results.
Today in Regulatory Issues...keeping you current
Receive free subspecialty "5-minute updates" via email
Avodart (dutasteride) Regulatory Update
GlaxoSmithKline, 10/02/09
Retigabine Regulatory Update
GlaxoSmithKline, 11/03/09
Beware of Tight 5010 Deadline
HealthDataManagement, 10/16/09
Article Search
Sponsor